Advanced malignant lung disease: what the specialist can offer.
about
Palliative endobronchial brachytherapy for non-small cell lung cancerChemical Pleurodesis Using Mistletoe Extraction (ABNOVAviscum(®) Injection) for Malignant Pleural EffusionMicroRNA-21 (miR-21) regulates cellular proliferation, invasion, migration, and apoptosis by targeting PTEN, RECK and Bcl-2 in lung squamous carcinoma, Gejiu City, China.MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung CancerNeodymium yttrium-aluminium-garnet laser resection significantly improves quality of life in patients with malignant central airway obstruction due to lung cancer.A Novel Self-Expandable, Radioactive Airway Stent Loaded with 125I Seeds: A Feasibility and Safety Study in Healthy Beagle Dog.MicroRNAs as therapeutic targets in chemoresistance.Supportive and palliative care of advanced nonmalignant lung disease.Bronchoscopic management of malignant airway obstruction.Switching off malignant pleural effusion formation-fantasy or future?Pregnane X receptors regulate CYP2C8 and P-glycoprotein to impact on the resistance of NSCLC cells to Taxol.Recent highlights of Chinese medicine for advanced lung cancer.Thoracic ultrasound demonstrates variable location of the intercostal artery.MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating SOCS1, SOCS6, and PTENTrichosanthin enhances the antitumor effect of gemcitabine in non-small cell lung cancer via inhibition of the PI3K/AKT pathway.Effectiveness and response predictive factors of erlotinib in a non-small cell lung cancer unselected European population previously treated: a retrospective, observational, multicentric study.A prospective nonrandomized phase I/II study of carbon ion radiotherapy in a favorable subset of locally advanced non-small cell lung cancer (NSCLC).The Clinical Influence of Autophagy-Associated Proteins on Human Lung Cancer.Safety and effectiveness of microdebrider bronchoscopy for the management of central airway obstruction
P2860
Q24202433-7567B058-F1BE-42B5-82AA-B4C3646B11E4Q28830501-CFE97191-F17A-45E7-9B02-7731FE03C381Q33989118-2686B36A-AC39-4D18-B9C9-46178FB727A2Q34785711-5E4E1D2D-2185-47C5-B782-0B62A2AF1DAEQ35369691-EFB68840-61D4-4E5A-86AD-6518333D909FQ36340668-49418377-BC99-4C4A-8F20-64839CF2C2A6Q37381107-23813D1D-D76A-4805-86B3-756D6049F8E5Q37932990-E7B9B57B-9C52-45B8-9B2C-E04EBFDC7424Q38213544-9DB2E481-E3F1-4B8A-A38B-5FB3F51B165AQ38543525-829FAAB6-F17C-4298-98EA-C8645793AD73Q38729384-E76E4BD5-E641-402B-9723-F2AB88DA2635Q38777343-11D6766A-7D7C-4688-9C65-902F53350B10Q39657131-CE256ED5-592F-4A6B-95E1-1E29689C11F1Q41890736-7040BC1C-125B-474F-86F9-7C03EE6B4402Q47147122-9CF0747E-DA8A-4646-9F9D-63D0289F4859Q51290257-B9CD50FA-4EC3-4FB7-9FD1-A14A1A035DFFQ53629230-5B56D11E-5A51-49EF-B90A-EB523B992988Q54997371-8C01E322-C405-4DA7-A552-D454FA24D0E4Q57895682-59E58EBE-5514-40A3-B7ED-B42C1A8AD64E
P2860
Advanced malignant lung disease: what the specialist can offer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Advanced malignant lung disease: what the specialist can offer.
@ast
Advanced malignant lung disease: what the specialist can offer.
@en
type
label
Advanced malignant lung disease: what the specialist can offer.
@ast
Advanced malignant lung disease: what the specialist can offer.
@en
prefLabel
Advanced malignant lung disease: what the specialist can offer.
@ast
Advanced malignant lung disease: what the specialist can offer.
@en
P2093
P2860
P356
P1433
P1476
Advanced malignant lung disease: what the specialist can offer.
@en
P2093
Daniel Gompelmann
F J F Herth
R Eberhardt
P2860
P304
P356
10.1159/000329703
P577
2011-07-15T00:00:00Z